Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
2476
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.14M | ﹤0.01% |
94,474
+9,500
| +11% | +$118K |
|
|
HALL
2477
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.14M | ﹤0.01% |
32,691
-37,947
| -54% | -$1.27M |
|
|
CVSA
2478
Covista Inc
CVSA
$4.49B
| $1.14M | ﹤0.01% |
+36,500
| New | +$1.14M |
|
|
ASNA
2479
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.14M | ﹤0.01% |
778,537
+231,500
| +42% | +$349K |
|
2480
Sasol
SSL
$7.37B
| $1.13M | ﹤0.01% |
146,800
-1,382,800
| -90% | -$7.57M |
|
2481
BeyondSpring
BYSI
$35.1M
| $1.13M | ﹤0.01% |
+75,000
| New | +$1.14M |
|
2482
Phreesia
PHR
$765M
| $1.13M | ﹤0.01% |
+40,000
| New | +$1.04M |
|
|
CDMO
2483
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.13M | ﹤0.01% |
172,306
-92,500
| -35% | -$516K |
|
2484
Amerant Bancorp
AMTB
$1.14B
| $1.13M | ﹤0.01% |
75,003
-17,500
| -19% | -$236K |
|
2485
Consumer Portfolio Services
CPSS
$208M
| $1.13M | ﹤0.01% |
398,258
+6,972
| +2% | +$17.4K |
|
|
VSA
2486
VisionSys AI
VSA
$9.3M
| $1.13M | ﹤0.01% |
290
-60
| -17% | -$450K |
|
2487
Ark Restaurants
ARKR
$20.2M
| $1.12M | ﹤0.01% |
90,815
+100
| +0.1% | +$1.17K |
|
|
TBRG
2488
DELISTED
TruBridge
TBRG
| $1.12M | ﹤0.01% |
49,176
-7,100
| -13% | -$158K |
|
2489
Fennec Pharmaceuticals
FENC
$417M
| $1.12M | ﹤0.01% |
134,000
+57,904
| +76% | +$431K |
|
2490
Black Diamond Therapeutics
BDTX
$116M
| $1.12M | ﹤0.01% |
+26,507
| New | +$976K |
|
2491
Astronics
ATRO
$4.54B
| $1.11M | ﹤0.01% |
126,600
-51,480
| -29% | -$402K |
|
|
SBBX
2492
DELISTED
SB One Bancorp Common Stock
SBBX
| $1.11M | ﹤0.01% |
56,200
-5,600
| -9% | -$97.2K |
|
2493
Coffee Holding Co
JVA
$20M
| $1.1M | ﹤0.01% |
368,143
+32,622
| +10% | +$91.6K |
|
2494
iShares MSCI ACWI ETF
ACWI
$33.5B
| $1.1M | ﹤0.01% |
+14,900
| New | +$1.04M |
|
|
JT
2495
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $1.09M | ﹤0.01% |
210,239
+19,775
| +10% | +$125K |
|
|
PFIE
2496
DELISTED
Profire Energy, Inc
PFIE
| $1.09M | ﹤0.01% |
1,303,932
+37,100
| +3% | +$30.8K |
|
|
WBT
2497
DELISTED
Welbilt, Inc.
WBT
| $1.08M | ﹤0.01% |
178,200
-1,164,300
| -87% | -$6.3M |
|
2498
UNIFI
UFI
$122M
| $1.08M | ﹤0.01% |
+84,134
| New | +$996K |
|
2499
Allogene Therapeutics
ALLO
$697M
| $1.08M | ﹤0.01% |
+25,200
| New | +$911K |
|
2500
ProShares Ultra QQQ
QLD
$14.3B
| $1.08M | ﹤0.01% |
+58,400
| New | +$895K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.